Investment in "health sciences" grows by 1001Tbp1T in Q2 2013
09/10/2013
Diego Gutiérrez
Investment in "health sciences" grows by 1001Tbp1T in Q2 2013

According to a report by Clipperton finance, the health sciences sector experienced solid growth (100%) in Q2 2013 over the previous quarter with several large deals (>$50M) in "Medtech" and "Biotech".

 

The health sector accounts for 29% of the total amount invested.

The healthcare sector attracted a significant share of the pie in the second quarter of the year with a growth of 100% with $453M. The IT sector topped the ranking with 62% representing a decrease of 5%. The cleantech sector reached the same level as the previous quarter with 9%.

"In Spain the sector has also accounted for a similar percentage of Venture Capital investments. In the second quarter there were 26 deals with €11M of investment. Significant was the sale of Endosense owned by Ysios. A significant round is expected to take place in the coming months. TCD Pharma"Diego Gutierrez, an expert in corporate finance, points out in ABRA INVEST.

Most relevant operations

The largest operation has been carried out by Auris Medical  $51M. The round was participated by Sofinnova partners and Sofinnova Ventures. The company will devote the investment to the development of its hearing loss drugs.

In second place comes the operation carried out in Opsona Therapeutics of $43M financed by BB BiotechSunstone, Baxter, Amgen and EMBL Ventures. The company focuses on inflammatory anti-immune diseases.

"In the USA, investment in the sector has accelerated, especially in companies oriented towards the reduction of waste. health costs and optimisation of resources, due to the Affordable Care Act, with which Obama intends to universalise healthcare. 47% of these investments in 2012 went to seed-stage companies," analyses Diego Gutierrez.

Lastest news

Amazon’s strategic acquisitions in 2024: A comprehensive analysis

En 2024, Amazon dio grandes pasos en la expansión de sus capacidades y su influencia en el mercado a través de una serie de adquisiciones de alto perfil. Estas adquisiciones reflejan el compromiso continuo de Amazon con la innovación, la diversificación y el dominio...

Do you want to sell or buy a company?

We are experts in M&A transactions in the technology sector.

Subscribe to our newsletter

Request for information

If you want to buy or sell a company, or need more information about our services, do not hesitate to contact us through the form.

Or if you prefer, call us at:

+34 946 42 41 42